ESC 2025: Digitoxin Trial Redefines Role of Glycosides in Heart Failure
DIGIT-HF trial finds digitoxin reduces death and heart failure hospitalisations in advanced HFrEF, complementing modern guideline therapies.| European Medical Journal
The findings suggest that a multi-marker, multi-pathway approach can account for the heterogeneous ways HCC emerges. The post Combining Biomarkers and Risk Scores to Detect Liver Cancer appeared first on European Medical Journal.| European Medical Journal
The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy. The post ESC 2025: First-Line Potential for Aficamten in Obstructive Cardiomyopathy appeared first on European Medical Journal.| European Medical Journal
In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients. The post ESC 2025: Starting SGLT2 Inhibitors in Hospital May Improve Heart Failure Outcomes appeared first on European Medical Journal.| European Medical Journal
To investigate the feasibility of RUTF for children with SCA, the SAMS trial in Nigeria enrolled 108 children aged five to twelve with severe acute malnutrition. The post Understanding Adherence to Nutritional Therapy in Sickle Cell appeared first on European Medical Journal.| European Medical Journal
A new study suggests that the common cold may boost children’s antiviral defences, lowering the risk and severity of COVID-19. The post Common Cold May Prime Children’s Defences Against COVID-19 appeared first on European Medical Journal.| European Medical Journal
The POTCAST trial shows raising plasma potassium to high-normal levels reduces ventricular arrhythmia risk, hospitalisations, and death in ICD patients. The post ESC 2025: Raising Potassium Reduces Ventricular Arrhythmia Risk in High-Risk Patients appeared first on European Medical Journal.| European Medical Journal
Patients with chronic lymphocytic leukemia (CLL) who consistently saw the same oncologist or hematologist experienced significantly fewer emergency room visits and hospitalizations, according to a large real-world study of nearly 6,000 individuals treated with covalent Bruton tyrosine kinase inhibitor (cBTKi) therapy. The post Hospitalizations Fall in Chronic Lymphocytic Leukemia Thanks to Continuity of Care appeared first on European Medical Journal.| European Medical Journal
Objective biometric measures showed improvement in both groups, but the combination therapy produced significantly greater benefits. The post New Treatment Shows Promise for Reducing Acne Scars appeared first on European Medical Journal.| European Medical Journal
Randomized clinical trials in Alzheimer's disease have grown substantially in scale and complexity over the past three decades, with modern studies increasingly designed to capture slower and more subtle therapeutic effects. The post Alzheimer’s Studies Evolve with Bigger, Slower Trials appeared first on European Medical Journal.| European Medical Journal
DIGIT-HF trial finds digitoxin reduces death and heart failure hospitalisations in advanced HFrEF, complementing modern guideline therapies.| European Medical Journal
Researchers identify gut-derived inflammatory molecules that trigger food-allergy-induced anaphylaxis in mice, pointing to new treatment strategies.| European Medical Journal
Understand how diabetes may raise bone density over time, but fracture risk remains.| European Medical Journal
EMJ is thrilled to present an interview with Massimo Colombo, Past Professor of Gastroenterology at the University of Milan, Italy, that...| European Medical Journal
Discover a study validating the TRIUMPH machine learning model, which improves prediction of post-transplant recurrence in liver cancer patients and enhances organ allocation decisions.| European Medical Journal
Learn how a safety bundle in assisted birth cut trauma and NICU rates, improving outcomes without raising neonatal complications.| European Medical Journal
Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and outcomes, especially in high-burden regions, audit shows.| European Medical Journal
NHS England mental health survey shows record rise in psychiatric conditions, self-harm, and suicidal ideation.| European Medical Journal
JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has...| European Medical Journal
Discover a study that links air pollution and climate extremes to increased severity and prevalence of atopic dermatitis.| European Medical Journal
Now, as a practicing physician, I have no insecurities about being a woman in business, because in my training, I would be in a room with...| European Medical Journal
Discover a study that demonstrates the effectiveness of guselkumab in treating scalp psoriasis, offering significant symptom relief.| European Medical Journal
Short pediatric EMU stays met clinical goals in 82% of cases. Drug-resistant epilepsy predicted both successful assessments and the need for future admissions, guiding resource planning.| European Medical Journal
Rabies is one of the oldest communicable diseases known to humans and is almost always fatal, with very few cases of survival...| European Medical Journal
Learn how brain MRI scores can predict neurological outcomes after cardiac arrest, a promising tool for survivor care.| European Medical Journal
New trial shows CagriSema leads to major weight loss and better glycaemic control in Type 2 diabetes.| European Medical Journal
Our independent, open-access journals are dedicated to delivering insights into ground-breaking changes and advancements in medicine| European Medical Journal
Learn how nightmares can speed up ageing and raise early death risk - discover the science and what you can do.| European Medical Journal
